Advertisement

Topics

Companies Related to "Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer" [Most Relevant Company Matches] RSS

05:08 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Study E7070 Combined With Capecitabine Determine Efficacy Recommended" Companies 1–25 of 1,100+

Relevant

Carclo plc

The company remains committed to the highest standards of corporate governance and manages its affairs in accordance with the 2003 FRC Combined Code on Corporate Governance (“the Combined Code”) published in July 2003. The company has complied throughout the year with the provisions set out in the Combined Code except where noted on page 26. This statement, together with the directors’ remun...


Combined Insurance

Combined Insurance is a leading provider of individual supplemental accident, disability, health and life insurance products and part of the ACE Group of Companies. With a field sales force and corporate staff in excess of 5,000 people worldwide, Combined Insurance meets the growing coverage needs of policyholders around the globe. For more information, ca...

Bionaut Pharmaceuticals Incorporated

Bionaut was founded in 2000 to develop proprietary small molecule drugs in several major disease areas. The company is also negotiating a limited number of drug development collaborations based on its patented Sentinel Linesâ„¢ technology.Bionaut utilizes engineered bioassays to identify new drug candidates which regulate gene expression. Combined with cell-based, high throughput screening met...


Abt Associates Clinical Trials

Abt Associates Clinical Trials (AACT) is a full-service Contract Research Organization dedicated to serving the pharmaceutical, biotechnology, and medical device industries. AACT works with our clients to determine the safety and efficacy of their drugs, biologics, and devices supporting the process of obtaining FDA and other regulatory approvals. In the pre-approval phases, we offer our clients a...

CLINICAL RESEARCH LABORATORIES, INC

Clinical Research Laboratories, Inc. (CRL) was incorporated in 1992. Today, CRL operates as an independent contract laboratory providing a wide range of clinical safety and efficacy testing to the cosmetic and pharmaceutical industries. Located in central New Jersey, CRL is dedicated to conducting human clinical test procedures to determine the safety and efficacy of cosmetic, personal care, and O...

Adamis Pharmaceuticals Corporation

La Jolla Pharmaceutical Company is a biopharmaceutical company. La Jolla had historically focused substantially all of its research, development and clinical efforts and financial resources toward the development of its Riquent® (abetimus sodium) product candidate, as a treatment for patients with lupus. In February 2009, La Jolla announced that an inde...

TheraCoat

TheraCoat is a specialty pharmaceutical company founded in 2004 by uro-oncologists and biomaterial specialists. TheraCoat’s Board of Directors and Scientific Advisory Board feature renowned scientific experts in the fields of urology, pharma top executives and experienced business veterans; among them Prof. Belldegrun and Mr. Hurvitz, both TEVA Board ...

Surveillance Data, Inc.

Custom database management projects where management, sales, and research are able to share and disseminate information efficiently. SDI acquires, creates, or redefines data to suit the needs of the client.Modeling to determine ROI, DTC, and trade promotion efficacy in the healthcare industry. SDI's clients depend upon us to develop the information sources needed to appropriately analyze the resul...

Children’s Oncology Group

The Children’s Oncology Group (COG), a National Cancer Institute supported clinical trials group, is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 8,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across ...

RealTime Laboratories, LLC

RealTime Laboratories, LLC (RTL) is a molecular biology and microbiology laboratory specializing in the detection of mycotoxins in human and environmental samples. RTL uses patented DNA testing to help patients and their physicians determine the effects of exposure to environmental toxins. To date, RTL has conducted the only peer reviewed and published research on the subject of contaminated drywa...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

KARD Scientific

KARD scientific is the reliable resource for all your in vivo efficacy studies in drug discovery and development. For high quality, efficiency and cost effective services in cancer, neurological, inflammation, arthritis and other disease models. We can assist you in study design and methods for screening. We optimize the schedule, time points, routes, and combination studies, while keeping cl...

Envoy Therapeutics, Inc.

Envoy Therapeutics’ mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues o...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Neuro-Hitech

Neuro-Hitech is focused specifically on the development and commercialization of next-generation therapies against proven targets for neurodegenerative diseases. The company’s signature offering, Huperzine A is being tested for efficacy in the treatment of Alzheimer's disease and the company has plans to study other degenerative disorders such as vascular dementia, mild cognitive impairment and ...

Envoy Therapeutics Inc.

Envoy Therapeutics’s mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues ...

Guildford Clinical Pharmacology

Guildford Clinical Pharmacology Ltd (GCPL) has wide experience of efficient study designs in Phases 1 & 2 and develops new surrogate markers especialy for analgesics, the CNS and gastrointestinal drugs. We can use high tech equipment and the staff to run it correctly; recent examples being: 1) Gamma cameras for colonic transit measurements in a proof of efficacy study on a morphine antagonist an...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Halo Healthcare, Inc.

Halo Healthcare is a diagnostic device company specializing in women’s breast health. The HALO® Breast Test is a 5-minute, non-invasive test that elicits NAF for subsequent cytopathology analysis to determine if there is the presence of abnormal cells from the breast ducts. The results of the HALO test help determine a woman’s risk of developing ...

Probably Relevant

Organogenesis Incorporated

Organogenesis Inc. designs, develops and manufactures medical therapeutics containing living cells and/or natural connective tissue. The company was formed to advance and apply the emerging field of tissue engineering to majormedical needs. Organogenesis' lead product, Apligraf(R), was launched in the US in June 1998. Apligraf is the only mass-manufactured product containing living human cells ...

Coeur Scientific Inc.

Coeur Scientific Inc. is a contract development company committed to providing expert consultations and complete in vivo, in vitro preclinical study management in a state-of-the-art professional environment. These services produce detailed and thorough information on the efficacy and safety of new medical devices, procedures and therapeutic agents. Our primary objective is to deliver quality dat...

BG Medical Technologies, Inc.

BG Medical Technologies is a medical marijuana company that develops technology and research software for cannabis and natural health solutions. The Company collects data through a network of proprietary software, utilized by patients, by retail operators, and by medical professionals. The Company's current flagship product, BudGenius.com, is a social web ...

invivodata, inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases ...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


More From BioPortfolio on "Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks